Frontiers in Cardiovascular Medicine (Sep 2018)
Mapping and Ablation of Idiopathic Ventricular Fibrillation
- Ghassen Cheniti,
- Ghassen Cheniti,
- Ghassen Cheniti,
- Konstantinos Vlachos,
- Konstantinos Vlachos,
- Marianna Meo,
- Stephane Puyo,
- Stephane Puyo,
- Nathaniel Thompson,
- Nathaniel Thompson,
- Arnaud Denis,
- Arnaud Denis,
- Josselin Duchateau,
- Josselin Duchateau,
- Masateru Takigawa,
- Masateru Takigawa,
- Claire Martin,
- Claire Martin,
- Claire Martin,
- Antonio Frontera,
- Antonio Frontera,
- Takeshi Kitamura,
- Takeshi Kitamura,
- Anna Lam,
- Anna Lam,
- Felix Bourier,
- Felix Bourier,
- Nicolas Klotz,
- Nicolas Klotz,
- Nicolas Derval,
- Nicolas Derval,
- Frederic Sacher,
- Frederic Sacher,
- Pierre Jais,
- Pierre Jais,
- Remi Dubois,
- Meleze Hocini,
- Meleze Hocini,
- Michel Haissaguerre,
- Michel Haissaguerre
Affiliations
- Ghassen Cheniti
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Ghassen Cheniti
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Ghassen Cheniti
- Department of Cardiology, Sahloul Hospital, Universite de Sousse, Sousse, Tunisia
- Konstantinos Vlachos
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Konstantinos Vlachos
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Marianna Meo
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Stephane Puyo
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Stephane Puyo
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Nathaniel Thompson
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Nathaniel Thompson
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Arnaud Denis
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Arnaud Denis
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Josselin Duchateau
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Josselin Duchateau
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Masateru Takigawa
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Masateru Takigawa
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Claire Martin
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Claire Martin
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Claire Martin
- Department of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom
- Antonio Frontera
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Antonio Frontera
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Takeshi Kitamura
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Takeshi Kitamura
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Anna Lam
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Anna Lam
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Felix Bourier
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Felix Bourier
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Nicolas Klotz
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Nicolas Klotz
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Nicolas Derval
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Nicolas Derval
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Frederic Sacher
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Frederic Sacher
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Pierre Jais
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Pierre Jais
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Remi Dubois
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Meleze Hocini
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Meleze Hocini
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- Michel Haissaguerre
- Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France
- Michel Haissaguerre
- IHU Liryc, Electrophysiology and Heart Modeling Institute, Foundation Bordeaux Université, Bordeaux, France
- DOI
- https://doi.org/10.3389/fcvm.2018.00123
- Journal volume & issue
-
Vol. 5
Abstract
Idiopathic ventricular fibrillation (IVF) is the main cause of unexplained sudden cardiac death, particularly in young patients under the age of 35. IVF is a diagnosis of exclusion in patients who have survived a VF episode without any identifiable structural or metabolic causes despite extensive diagnostic testing. Genetic testing allows identification of a likely causative mutation in up to 27% of unexplained sudden deaths in children and young adults. In the majority of cases, VF is triggered by PVCs that originate from the Purkinje network. Ablation of VF triggers in this setting is associated with high rates of acute success and long-term freedom from VF recurrence. Recent studies demonstrate that a significant subset of IVF defined by negative comprehensive investigations, demonstrate in fact subclinical structural alterations. These localized myocardial alterations are identified by high density electrogram mapping, are of small size and are mainly located in the epicardium. As reentrant VF drivers are often colocated with regions of abnormal electrograms, this localized substrate can be shown to be mechanistically linked with VF. Such areas may represent an important target for ablation.
Keywords